M&R Capital Management’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

M&R Capital Management’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-76,819	Closed	-$7.49K	–	654
2022 Q4	$7.49K	Hold	76,819	–	–	﹤0.01%	383
2022 Q3	$18K	Hold	76,819	–	–	0.01%	288
2022 Q2	$33K	Hold	76,819	–	–	0.01%	253
2022 Q1	$53K	Buy	+76,819	New	+$74.1K	0.01%	232

M&R Capital Management's SCPS Position: Q1 2023 in Review

M&R Capital Management sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q1 2023, closing a stake of 76,819 shares — an estimated $7.49K sold.

M&R Capital Management first reported a position in SCPS in Q1 2022 and held it in 4 quarters. The position peaked at $53K in Q1 2022. 0 funds tracked by Wall St. Rank hold SCPS as of Q1 2023.

M&R Capital Management reported no remaining Scopus BioPharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
M&R Capital Management sold 76,819 Scopus BioPharma Inc. Common Stock shares in Q1 2023, an estimated $7.49K.
M&R Capital Management first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2022 and held it in 4 quarters.
M&R Capital Management's Scopus BioPharma Inc. Common Stock position peaked at $53K in Q1 2022.
0 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q1 2023.

Based on M&R Capital Management's 13F filing for Q1 2023, filed 3 Apr 2023.